PHARMA VALUE DEMONSTRATION BIDCO LIMITED

Active London

Activities of other holding companies n.e.c.

0 employees website.com
Activities of other holding companies n.e.c.
P

PHARMA VALUE DEMONSTRATION BIDCO LIMITED

Activities of other holding companies n.e.c.

Founded 16 Jun 2020 Active London, United Kingdom 0 employees website.com
Activities of other holding companies n.e.c.
Accounts Submitted 4 Nov 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 7 Nov 2025 Next due 21 Nov 2026 5 months remaining
Net assets £28M £16M 2024 year on year
Total assets £294M £3M 2024 year on year
Total Liabilities £266M £12M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Great Suffolk Yard 127-131 Great Suffolk Street London SE1 1PP United Kingdom

Full company profile for PHARMA VALUE DEMONSTRATION BIDCO LIMITED (12674221), an active company based in London, United Kingdom. Incorporated 16 Jun 2020. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£169.71k

Decreased by £2.55M (-94%)

Net Assets

£27.87M

Decreased by £15.67M (-36%)

Total Liabilities

£265.82M

Increased by £12.38M (+5%)

Turnover

N/A

Employees

N/A

Debt Ratio

91%

Increased by 6 (+7%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 42,027,818 Shares £42.03m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 Oct 202011,244,588£11.24m£1
7 Aug 20202,009,589£2.01m£1
30 Jul 202028,698,641£28.70m£1
13 Jul 202075,000£75k£1

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Lumanity Limited
100.0%

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased

Terrance Mullen

American

Active
Notified 16 Jun 2020
Residence United States
DOB November 1966
Nature of Control
  • Significant Influence Or Control

Jeffrey Kovach

American

Active
Notified 16 Jun 2020
Residence United States
DOB August 1973
Nature of Control
  • Significant Influence Or Control
Active
Notified 21 Oct 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent
Ceased

Group Structure

Group Structure

PHARMA VALUE DEMONSTRATION BIDCO LIMITED Current Company
CELLO HEALTH LIMITED united kingdom

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Nov 2025Confirmation StatementConfirmation statement made on 7 Nov 2025 with no updates
4 Nov 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
4 Nov 2025AccountsAnnual accounts filed
4 Nov 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
4 Nov 2025AccountsAnnual accounts made up to 31 Dec 2024
7 Nov 2025 Confirmation Statement

Confirmation statement made on 7 Nov 2025 with no updates

4 Nov 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

4 Nov 2025 Accounts

Annual accounts filed

4 Nov 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

4 Nov 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Confirmation statement made on 7 Nov 2025 with no updates

7 months ago on 7 Nov 2025

Audit exemption statement of guarantee by parent company for period ending 31/12/24

7 months ago on 4 Nov 2025

Annual accounts filed

7 months ago on 4 Nov 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

7 months ago on 4 Nov 2025

Annual accounts made up to 31 Dec 2024

7 months ago on 4 Nov 2025